ALC:NYSE
Alcon AG
$74.39
arrow_downward
-0.15%(-0.11) 1D
Nov 20, 2:46:49 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
$74.16
High
$75.04
Low
$74.10
Mkt. cap
31.15B
Avg. vol.
2.43M
Volume
1.97M
52-wk high
$87.64
52-wk low
$61.84
Beta
0.87
Shares outstanding
480.40M
No. of employees
25K
Open
$74.16
High
$75.04
Low
$74.10
Mkt. cap
31.15B
Avg. vol.
2.43M
Volume
1.97M
52-wk high
$87.64
52-wk low
$61.84
Beta
0.87
Shares outstanding
480.40M
No. of employees
25K
News stories
From web sources and news partners
ad-hoc-news.de
·
3 hours ago
Alcon stock: Pershing Square takes a $954 million stake
TradingView
·
12 hours ago
Alcon Inc. Stock 12‑Month Price Target Raised to $86.4, Implies 16% Upside
Yahoo Finance
·
22 hours ago
Why Pershing Square Is Betting Big on Alcon Stock
Zacks
·
2 days ago
What Drove Glaukos Stock's 48% Rally Since the End of September?
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25K
Founded1945
HeadquartersGeneva, Geneva, Switzerland
SectorHealth Care
IndustryMedical device
Websitealcon.com